137 related articles for article (PubMed ID: 21879391)
1. In vitro and in vivo investigation of drug-eluting implants for the treatment of periodontal disease.
Lee FY; Chen DW; Hu CC; Hsieh YT; Liu SJ; Chan EC
AAPS PharmSciTech; 2011 Dec; 12(4):1110-5. PubMed ID: 21879391
[TBL] [Abstract][Full Text] [Related]
2. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
Kilicarslan M; Koerber M; Bodmeier R
Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants.
Ramchandani M; Robinson D
J Control Release; 1998 Jul; 54(2):167-75. PubMed ID: 9724903
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of metronidazole from composite poly-ε-caprolactone/alginate (PCL/alginate) rings for dental implants.
Lan SF; Kehinde T; Zhang X; Khajotia S; Schmidtke DW; Starly B
Dent Mater; 2013 Jun; 29(6):656-65. PubMed ID: 23602170
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of PLA and PLGA in situ implants containing secnidazole and/or doxycycline for treatment of periodontitis.
Gad HA; El-Nabarawi MA; Abd El-Hady SS
AAPS PharmSciTech; 2008; 9(3):878-84. PubMed ID: 18654864
[TBL] [Abstract][Full Text] [Related]
6. Modification of the release characteristics of estradiol encapsulated in PLGA particles via surface coating.
Enayati M; Stride E; Edirisinghe M; Bonfield W
Ther Deliv; 2012 Feb; 3(2):209-26. PubMed ID: 22834198
[TBL] [Abstract][Full Text] [Related]
7. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
Desai KG; Mallery SR; Schwendeman SP
Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
[TBL] [Abstract][Full Text] [Related]
8. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release delivery of octreotide from biodegradable polymeric microspheres.
Rhee YS; Sohn M; Woo BH; Thanoo BC; DeLuca PP; Mansour HM
AAPS PharmSciTech; 2011 Dec; 12(4):1293-301. PubMed ID: 21948321
[TBL] [Abstract][Full Text] [Related]
10. Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
Wischke C; Zhang Y; Mittal S; Schwendeman SP
Pharm Res; 2010 Oct; 27(10):2063-74. PubMed ID: 20668921
[TBL] [Abstract][Full Text] [Related]
11. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
Wang SH; Liang ZH; Zeng S
Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
[TBL] [Abstract][Full Text] [Related]
12. Effect of ethylcellulose and propylene glycol on the controlled-release performance of glyceryl monooleate-mertronidazole periodontal gel.
Sallam AS; Hamudi FF; Khalil EA
Pharm Dev Technol; 2015 Mar; 20(2):159-68. PubMed ID: 24262092
[TBL] [Abstract][Full Text] [Related]
13. In vitro / in vivo evaluation of NCDS-micro-fabricated biodegradable implant.
Park CW; Rhee YS; Park SH; Danh SD; Ahn SH; Chi SC; Park ES
Arch Pharm Res; 2010 Mar; 33(3):427-32. PubMed ID: 20361308
[TBL] [Abstract][Full Text] [Related]
14. Rheological properties of PLGA film-based implants: correlation with polymer degradation and SPf66 antimalaric synthetic peptide release.
Santoveña A; Alvarez-Lorenzo C; Concheiro A; Llabrés M; Fariña JB
Biomaterials; 2004 Feb; 25(5):925-31. PubMed ID: 14609681
[TBL] [Abstract][Full Text] [Related]
15. Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes.
Chen DW; Hsu YH; Liao JY; Liu SJ; Chen JK; Ueng SW
Int J Pharm; 2012 Jul; 430(1-2):335-41. PubMed ID: 22521880
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
Malathi S; Balasubramanian S
J Biomed Nanotechnol; 2011 Feb; 7(1):150-1. PubMed ID: 21485846
[TBL] [Abstract][Full Text] [Related]
17. High-throughput screening of PLGA thin films utilizing hydrophobic fluorescent dyes for hydrophobic drug compounds.
Steele TW; Huang CL; Kumar S; Widjaja E; Chiang Boey FY; Loo JS; Venkatraman SS
J Pharm Sci; 2011 Oct; 100(10):4317-29. PubMed ID: 21607953
[TBL] [Abstract][Full Text] [Related]
18. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
[TBL] [Abstract][Full Text] [Related]
19. Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis.
Tamazawa G; Ito A; Miyai T; Matsuno T; Kitahara K; Sogo Y; Kimishima K; Satoh T
Dent Mater J; 2011; 30(3):264-73. PubMed ID: 21597226
[TBL] [Abstract][Full Text] [Related]
20. Sustained local delivery of high-concentration vancomycin from a hybrid biodegradable, antibiotic-eluting, nanofiber-loaded endovascular prosthesis for treatment of mycotic aortic aneurysms.
Liu KS; Lee CH; Lee D; Liu M; Tsai FC; Tseng YY
J Vasc Surg; 2018 Aug; 68(2):597-606. PubMed ID: 29066243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
